ELOVL1 anticorps (N-Term)
Aperçu rapide pour ELOVL1 anticorps (N-Term) (ABIN5514396)
Antigène
Voir toutes ELOVL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- RGFMIVYNFS LVALSLYIVY EFLMSGWLST YTWRCDPVDY SNSPEALRMV
-
Homologie
- Cow: 86%, Dog: 100%, Guinea Pig: 100%, Horse: 93%, Human: 100%, Mouse: 86%, Rabbit: 100%, Rat: 100%, Zebrafish: 79%
-
Attributs du produit
- This is a rabbit polyclonal antibody against ELOV1. It was validated on Western Blot.
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N-terminal region of Human ELOV1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- ELOVL1 (ELOVL Fatty Acid Elongase 1 (ELOVL1))
-
Autre désignation
- ELOV1
-
Sujet
-
ELOV1 is a condensing enzyme that catalyzes the synthesis of both saturated and monounsaturated very long chain fatty acids (VLCFAs). It exhibits activity toward saturated C18 to C26 acyl-CoA substrates, with the highest activity towards C22:0 acyl-CoA. It is important for saturated C24:0 and monounsaturated C24:1 sphingolipid synthesis. Indirectly inhibits RPE65 via production of VLCFAs.
Alias Symbols: ELOVL1, SSC1, CGI-88,
Protein Interaction Partner: UBC, HSD17B12, CERS2, TECR, GLP1R, TWF2, PSMD10,
Protein Size: 279 -
ID gène
- 64834
-
NCBI Accession
- NP_073732
-
UniProt
- Q9BW60
Antigène
-